Regulatory Updates
Sep 25, 2026•1 min read
FDA Discontinues Testosterone Enanthate Injectable Products (ANDA083667)
The FDA has discontinued two injectable testosterone enanthate products from Watson Labs, listed under ANDA083667.
Regulatory Updates
Sep 19, 2026•1 min read
FDA Discontinues Testosterone Injectable (Product 001) – Submission History
The FDA has marked the testosterone injectable (product 001) as discontinued, with a record of multiple labeling and manufacturing submissions dating back to 1983.